Hiroshi Mayahara
Kobe, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Time to Oligoprogression From the Initiation of the Most Recent Systemic Treatment Is Associated With the Outcome of Progressive Site-Directed Therapy for Castration-Resistant Prostate Cancer.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: April 21, 2025
Intensity-Modulated Radiotherapy for Locally Advanced Lung Cancer in the Immunotherapy Era: A Prospective Study WJOG12019L.
Journal: JTO clinical and research reports
Published: January 27, 2025
Radiotherapy treatment planning for esophageal cancer: JASTRO guidelines 2024 for radiotherapy treatment planning.
Journal: Journal of radiation research
Published: January 27, 2025
Contouring atlas and essential points for radiotherapy in rectal cancer.
Journal: Journal of radiation research
Published: December 04, 2024
Respiratory motion tracking of spine stereotactic radiotherapy in prone position.
Journal: Journal of applied clinical medical physics
Published: July 11, 2022
Evaluation of robustness of optimization methods in breast intensity-modulated radiation therapy using TomoTherapy.
Journal: Physical and engineering sciences in medicine
Published: May 06, 2022
The efficacy profiles of concurrent chemoradiotherapy with intensity-modulated radiotherapy followed by durvalumab in patients with unresectable stage III non-small cell lung cancer: A multicenter retrospective cohort study.
Journal: Clinical and translational radiation oncology
Published: May 03, 2022
Fiducial marker position affects target volume in stereotactic lung irradiation.
Journal: Journal of applied clinical medical physics
Published: February 09, 2022
Survey of malignant pleural mesothelioma treatment in Japan: Patterns of practice and clinical outcomes in tomotherapy facilities.
Journal: Journal of radiation research
Published: September 06, 2021
Predicting factors of symptomatic radiation pneumonitis induced by durvalumab following concurrent chemoradiotherapy in locally advanced non-small cell lung cancer.
Journal: Radiation oncology (London, England)
Published: August 24, 2021
Last Updated: 09/26/2026